@ARTICLE{
author={Sheitanov Y,Povoroznyuk V,Dimic Aleksandar N,Bookbinder S,George M,Gauler G,von Hinuber U,Walker D,Braun Juergen,Fear S,Fritchley S,Tansley R,Baker H},
year={2007},
title={A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={66},
number={},
pages={448-448},
document_type={Meeting Abstract},
}